1. DOP69 Ozanimod for induction treatment of Moderate-to-Severe Ulcerative Colitis: Results from a systematic literature review and network meta-analyses. (27th May 2021) Authors: Eaton, K; Duperrouzel, C; Bhandari, P; Craigie, S; Bonner, A; Cameron, C; Tencer, T; Kumar, J Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1785 Hemodynamic determinants of left atrial function in patients with primary mitral regurgitation. (17th January 2020) Authors: Tencer, T; Bakkestroem, R; Banke, A; Moeller, J E Journal: European heart journal Issue: Volume 21(2020)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P468 Evaluation of work productivity and activity impairment in moderate-to-severe ulcerative colitis participants treated with ozanimod in the phase 3 True North study. (21st January 2022) Authors: Floden, L; Pham, T P; Kumar, J; Becker, B; Shaw, J W; Tencer, T Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i441 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P540 Real-world evidence on treatment switching in patients with moderate-to-severe ulcerative colitis: a systematic review of literature. (27th May 2021) Authors: Singh, H; Wilson, L; Pandey, A; Tencer, T; Kumar, J Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S511 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗